RNAGENE

Pipe

Pipeline

Category Indication Product Discovery

Pre-clinical

Clinical Phase
Phase 1 Phase 2 Phase 3
Prophylactic Vaccine SARS-CoV-2 RGV-019        
Influenza RGV-105        
Zika virus RGV-209        
Cancer Immunotherapy NSCLC RGS-371        
Multiple solid tumors RGS-365        
PRT Rare Disease RGD-404